ReviewRheumatology international2024

Baricitinib for anti-melanoma differentiation-associated protein 5 antibody-positive dermatomyositis-associated interstitial lung disease: a case series and literature review on Janus kinase inhibitors for the disease.

Hiroaki Harada et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.